Tuberculosis

Nature Reviews Microbiology

Volumn 2, Issue 12, 2004, Pages 930-932

  Onyebujoh, Phillip ^a   Rook, Graham A W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DIHYDRO 2 NITRO 6 (4 TRIFLUOROMETHOXYBENZYLOXY) 5H IMIDAZO[2,1 B][1,3]OXAZINE; BCG VACCINE; DNA VACCINE; ETHAMBUTOL; GAMMA INTERFERON; GATIFLOXACIN; HYBRID PROTEIN; INTERLEUKIN 12; ISONIAZID; KRQ 11018; LEVOFLOXACIN; LL 4858; MOXIFLOXACIN; MTB 72F; NITROIMIDAZOLE DERIVATIVE; OFLOXACIN; PLACEBO; PYRAZINAMIDE; PYRIDONE DERIVATIVE; QUINOLIZINE DERIVATIVE; RBCG 30; RECOMBINANT VACCINE; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; RIFAPENTINE; TUBERCULIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DNA REPAIR; DRUG TARGETING; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNITY; INCIDENCE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; THORAX RADIOGRAPHY; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTITUBERCULAR AGENTS; CLINICAL TRIALS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES; WORLD HEALTH;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 9444283279     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1050     Document Type: Note

References (27)

1. Espinal, M. A. et al. N. Engl. J. Med. 344, 1294-1303 (2001).
2. WHO Report No. WHO/HTM/TB/2004.331(2004).
3. Kumari, S. & Ram, V. J. Drugs Today 40, 487-500 (2004).
4. Hingley-Wilson, S. M. et al. Nature Immunol. 4, 949-955 (2003).
5. Pethe, K. et al. Nature 412, 190-194 (2001).
6. Kaushal, D. et al. Proc. Natl Acad. Sci. USA 99, 8330-8335 (2002).
7. Hsu, T. et al. Proc. Natl Acad. Sci. USA 100, 12420-12425 (2003).
8. Kremer, K. et al. J. Clin. Microbiol. 42, 4040-4049 (2004).
9. Rad, M. E. et al. Emerg. Infect. Dis. 9, 838-845 (2003).
10. Keane, J. et al. N. Engl. J. Med. 345, 1098-1104 (2001).
11. Hernandez-Pando, R. et al. Lancet 356, 2133-2138 (2000).
12. Voskuil, M. I. et al. J. Exp. Med. 198, 705-713 (2003).
13. Sly, L. M. et al. J. Immunol. 170, 430-437 (2003).
14. Fortune, S. M. et al. J. Immunol. 172, 6272-6280 (2004).
15. Rook, G. A. et al. Trends Immunol. 25, 483-488 (2004).
16. Hernandez-Pando, R. et al. Eur. J. Immunol. 34, 174-183 (2004).
17. Manca, C. et al. Infect. Immun. 72, 5511-5514 (2004).
18. Demissie, A. et al. J. Immunol. 172, 6938-6943 (2004).
19. Fletcher, H. A. et al. Immunology 112, 669-673 (2004).
20. Horwitz, M. A. & Harth, G. Infect. Immun. 71, 1672-1679 (2003).
21. Skeiky, Y. A. et al. J. Immunol. 172, 7618-7628 (2004).
22. Goonetilleke, N. P. et al. J. Immunol. 171, 1602-1609 (2003).
23. Okkels, L. M. et al. Proc. Natl Acad. Sci. USA 95 5299-5304 (2003).
24. Hess, J. et al. Proc. Natl Acad. Sci. USA 95, 5299-5304 (1998).
25. Zuany-Amorim, C. et al. Nature Med. 8, 625-629 (2002).
26. Luo, Y. et al. Zhonghua Jie He He Hu Xi Za Zhi 23 85-88 (2000).
27. Richeldi, L. et al. Am. J. Respir. Crit. Care Med. 170, 288-295 (2004).